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Abstract
A subtype of microglia is defined by the morphological appearance of the cells as rod-shaped. 
Little is known about this intriguing cell type, as there are only a few case reports describing rod-
shaped microglia in the neuropathological literature. Rod-shaped microglia were shown recently to 
account for a substantial proportion of the microglia cells in the hippocampus of both demented 
and cognitively intact aged individuals. We hypothesized that aging could be a defining feature in 
the occurrence of rod-shaped microglia. To test this hypothesis, two independent series of autopsy 
cases (total n=168 cases), which covered the adult lifespan from 20 – 100+ years old, were 
included in the study. The presence or absence of rod-shaped microglia was scored on IBA1 
immunohistochemically stained slides for the hippocampus and cortex. We found that age was one 
of the strongest determinants for the presence of rod-shaped microglia in the hippocampus and the 
cortex. We found no association with the presence of rod-shaped microglia and a self-reported 
history of a TBI. Alzheimer’s disease related pathology was found to influence the presence of 
rod-shaped microglia, but only in the parietal cortex and not in the hippocampus or temporal 
cortex. Future studies are warranted to determine the functional relevance of rod-shaped microglia 
in supporting the health of neurons in the aged brain, and the signaling processes that regulate the 
formation of rod-shaped microglia.
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1. Introduction
Microglia are the resident tissue macrophage of the central nervous system (CNS). In the 
healthy CNS, microglia form a network of nearly uniformly distributed cells throughout the 
tissue, with thin highly ramified cell processes. Changes in microglia morphology away 
from the ramified or ‘surveying’ type of cell are well described in the literature, but largely 
center around the hypertrophic or ‘activated’ morphology. Despite recent studies defining a 
number of additional microglia morphologies (Bachstetter et al., 2015, Roth et al., 2014, 
Streit, 2006, Ziebell et al., 2012), little is known about the relevance of these morphological 
changes to human brain health and disease.
First described by Franz Nissl over 100 years ago (reviewed in (Graeber, 2010)), rod-shaped 
microglia are a particularly intriguing morphologically-defined subtype. The modern 
literature describing rod-shaped microglia is sparse, and is dominated by case reports, with 
the exception of a recent study that determined the relative amount of rod-shaped microglia 
in the hippocampus of different age-related neurodegenerative diseases (Bachstetter et al., 
2015). Rod-shaped microglia were found in approximately 60% of the cases, including a 
subset of non-demented control cases, as well as in cases with different neurodegenerative 
disease (Bachstetter et al., 2015). The high prevalence of rod-shaped microglia in individuals 
65 years or older suggested that aging or an age-related degenerative process might be an 
important predictor for the presence of rod-shaped microglia.
In this study we sought to determine if aging, Alzheimer’s disease, or traumatic brain injury 
(TBI) could be a defining feature in the occurrence of rod-shaped microglia in the human 
brain. To this end we used two independent series of cases. The first series included 61 cases 
that covered the adult lifespan from 20 – 96 years of age, which were free of advanced 
neurodegenerative pathology. The second set of 107 cases were from an aged population-
based series, with an age range of 77 – 100+ years old, which included non-demented 
controls and cases with Alzheimer’s disease. We found that older chronological age was a 
strong predictor for the presence of rod-shaped microglia, even when controlling for 
Alzheimer’s disease pathology. Our data suggest that there may be an age-related change to 
neurons or microglia, which we have yet to define, that predisposes the aged brain to the 
presence of rod shaped microglia.
2. Materials and Methods
2.1 UK series: University of Kentucky human subjects, and tissue processing
A set of 61 autopsy cases were collected from the University of Kentucky (UK) bio tissue 
repository (Table 1). The cases were selected to cover the adult lifespan from 20 - 96 years 
of age. Cases were selected by the investigators (JHN and PTN) to be free of advanced 
neurodegenerative pathology. Exclusion criteria included pathologically confirmed 
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neurodegenerative disease: specifically, but not limited to, advance disease pathology 
associated with Alzheimer’s disease, dementia with Lewy bodies, hippocampal sclerosis of 
aging, and vascular dementia. To identify rod-shaped microglia, brains were stained with the 
IBA1 (ionized calcium binding adaptor molecule 1) antibody, which is used as a pan marker 
of macrophages / microglia in the brain. Paraffin-embedded tissue was processed, 8μm-thick 
sections were cut, and immunohistochemical (IHC) staining was done using the primary 
antibody: IBA1 (rabbit polyclonal, 1:1,000 IHC, Wako Pure Chemical Industries, Richmond, 
VA). A biotinylated secondary antibody (Vector Laboratories) was amplified using avidin-
biotin substrate (ABC solution, Vector Laboratories catalog no. PK-6100), followed by color 
development in Nova Red (Vector Laboratories). The Aperio ScanScope XT digital 
slidescanner was used to image the entire stained slide at 40x magnification to create a 
single high-resolution digital image. A tissue section from the hippocampus and the frontal 
cortex was analyzed by two observers blind to the experimental conditions (YH and DA). 
The observers exhaustively inspected the gray matter of the entire slides for the presence of 
rod-shaped microglia at a minimum of 8x magnification. Presence of rod-shaped microglia 
was defined as at least 1 clearly defined rod-shaped microglia: Figure 1 shows examples of 
cells defined as rod-shaped microglia.
2.2 AI-ACT series: Aging, Dementia and Traumatic Brain Injury study of the Allen Institute 
(AI) for Brain Science
The Aging, Dementia and Traumatic Brain Injury Study is a series of 107 autopsy cases with 
and without a history of traumatic brain injury drawn from the Adult Changes in Thought 
(ACT) study (AI-ACT)) (Table 1). Data used for the current project are publically available 
through the AI website (© 2016 Allen Institute for Brain Science. Aging, Dementia and 
TBI. Available from: http://aging.brain-map.org/overview/explore). High magnification 
digital histopathological images of the entire physical slides are available to download for 
three brain regions—hippocampus, temporal cortex, and parietal cortex—for a number of 
neuropathological stains. Additional information is available in the AI-ACT database, 
including results from extensive biochemical assays, and clinical information about the 
cases. To determine how often rod-shaped microglia were found in this sample population, 
the digital histopathological images of IBA1 for the hippocampus, temporal cortex and 
parietal cortex were downloaded (all regions were not available for all cases), and were 
independently scored by three observers blind to the experimental conditions (YH, DA, and 
ADB) for the presence or absence of rod-shaped microglia in the gray matter. Presence of 
rod-shaped microglia was defined as at least 1 clearly defined rod-shaped microglia: Figure 
1 shows examples of cells defined as rod-shaped microglia.
2.3 Statistics
JMP Pro Software version 12.0 or SAS 9.4 (SAS Institute, Inc.; Cary, NC, USA) was used 
for statistical analysis. Statistical significance was set at 0.05. Contingency tables of 
categorical variables (presence of rod shaped microglia, sex, age group, history of TBI) were 
compared using the Pearson chi-square test or Fisher’s exact test. The Cochran-Armitage 
Test was used to assess for a linear trend in the association between age and frequency of 
rod-shaped microglia. Logistic regression was used to assess the variable of interest (age) 
and potential confounders (sex, dementia status, Braak neurofibrillary tangle (NFT) stage, 
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and Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuritic plaque 
rating) and to estimate odds ratios (OR) for the presence of rod-shaped microglia. Age 
groups were generated by a median split into 20–69 years old and 70 years old or older for 
the UK series, and 70–89 years old and 90 years old or older group for the AI-ACT series. 
Availability of confounder variables differed in the UK and AI-ACT cohorts. For UK, only 
sex (coded male = 1, female = 2) was available for all cases. For the AI-ACT series, 
additional variables were available: sex was coded as male = 1, female = 2, Braak NFT stage 
was coded as low (stage 0/I/II), moderate (III/IV), or high (V/VI); CERAD neuritic plaque 
rating was coded as none, sparse, moderate, or frequent; dementia status was coded as no 
dementia vs. dementia (DSM-IV criteria). Multivariable regression models to adjust 
clinicopathological associations for potential confounding factors have been used multiple 
times by our group (Abner et al., 2016, Abner et al., 2014, Ighodaro et al., 2017, Nelson et 
al., 2010). Comparisons between the AI-ACT series versus UK series were done using a 
logistic regression to determine ORs for presence of rod-shaped microglia in the 
hippocampus of older aged individuals (70–89 years old).
In preclinical animal models, TBI has been shown to be a strong initiator for the presence of 
rod-shaped microglia; therefore, we sought to determine if a history of TBI exposure in the 
AI-ACT series could be associated with the presence of rod-shaped microglia. As part of the 
ACT study design participants were asked at initial enrollment to the study and at the 
biannual re-evaluation about exposure to a brain injury that caused a loss of consciousness 
(Dams-O’Connor et al., 2013). Cases reporting a history of TBI with a loss of consciousness 
were compared to those without a history of TBI for the presence of rod-shaped microglia. 
To determine if more severe TBI could be associated with the presence of rod-shaped 
microglia, cases with a self-reported loss of consciousness of more than 10 minutes were 
compared to the cases with no TBI exposure.
3. Results
3.1 Age is associated with increased presence of rod-shaped microglia in the University of 
Kentucky (UK) aging series
The primary research question was to elucidate the clinical-pathological correlations 
associated with the occurrence of rod-shaped microglia in postmortem hippocampal and 
cortical tissue. We first sought to determine if aging was accompanied by an increase 
incidence of IBA1+ rod-shaped microglia. Examples of rod-shaped microglia identified in 
the tissue of the aging UK series are shown in Figure 1. In the hippocampus a significant 
trend for an increased occurrence of any rod-shaped microglia with increasing age was 
found (Fig 2A). Separating the cases into younger adults (20–69 years old; n=35) to the 
older adults (70+ years old; n=26), at the time of death (using a median split of the cases), 
we found a significantly greater proportion of any rod-shaped microglia in hippocampus of 
older adults (46.2%) compared to younger adults (11.4%) (Fig 2B). The age-related increase 
in the presence of rod-shape microglia remained significant when corrected for sex 
(p=0.005). The OR for presence of rod-shaped microglia in the older adults versus the 
younger adults was 6.64 (95% confidence interval (CI) 1.94–27.25), and when corrected for 
sex the OR was 5.87 (95% CI 1.66–24.8); the reduction in magnitude was likely due to the 
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fact that females in the UK series were both more likely to be older and more likely to have 
rod-shaped microglia in the hippocampus. In the frontal cortex, a similar age-related 
increase in the proportion of individuals with any rod-shaped microglia was found (Fig 2C–
D); however, this increase was not statistically significant.
To further explore the age-related differences in the occurrence of rod-shaped microglia, the 
cases were subdivided by which brain region(s) rod-shaped microglia were found, as 
follows: 1) in the hippocampus only, 2) in the cortex only, or 3) in both the cortex and the 
hippocampus (Fig 3). In those individuals less than 70 years old, rod-shaped microglia were 
found in the frontal cortex, or the hippocampus, but not in both the hippocampus and frontal 
cortex (Fig 3). This was in contrast to the older adults, where 19.2% of the cases were found 
to have rod-shaped microglia in the frontal cortex and hippocampus.
3.2 Age, and not traumatic brain injury (TBI) or Alzheimer’s disease related pathology, was 
associated with the presence of rod-shaped microglia in the AI-ACT series
To further explore the occurrence of rod-shaped microglia in older individuals we used the 
public data repository released by the Allen Institute (AI) for Brain Science (© 2016 Allen 
Institute for Brain Science. Aging, Dementia and TBI. Available from: http://aging.brain-
map.org/overview/explore). Overall we found that the percentage of cases positive for rod-
shaped microglia in the hippocampus in the older aged individuals (70–89 years old) was 
higher in the AI-ACT series compared to the UK series (UK = 42.9% 9/21; AI-ACT = 
65.1% 28/430. The OR for AI-ACT (70–89 years old) vs UK series (70–89 years old) to 
have rod-shaped microglia in the hippocampus was 2.49 (95% CI, 0.86–7.44). The data 
suggested that increased age and/or Alzheimer’s disease pathology found in the AI-ACT 
series in comparison to the UK series (Table 1) may be associated with the increased 
presence of rod-shaped microglia in the AI-ACT series.
Since the AI-ACT series contained oldest-old individuals, we also sought to determine 
whether oldest-old age (90+ years old) was associated with increased presence of rod-
shaped microglia relative to younger old (70–89 years old). In the hippocampus, the 
unadjusted OR for 90+ vs. 70–89 was 1.30 (95% CI 0.54–1.86), suggesting no significant 
effect of oldest-old age on the presence of rod-shaped microglia in this region. In the parietal 
cortex, the OR was 0.86 (95% CI 0.34–2.16), and in the temporal cortex the OR was 3.27 
(95% CI 1.43–7.73), which may suggest that age effects are region-specific (Table 2). To 
evaluate if age was independently associated with presence of rod-shaped microglia after 
controlling for Alzheimer’s disease pathology in the AI-ACT series, a logistic regression 
analysis was done to determine if sex, Braak NFT Stage, CERAD neuritic plaque score, and 
dementia status were potential confounders of the age-microglia relationship. The age effect 
remained significant in the temporal cortex (Fig 4A, Table 2) after adjustment, but there 
were also strong effects for dementia and sparse and moderate plaques in the parietal cortex, 
although confidence intervals were wide (Table 2). There were no significant associations 
between rod-shaped microglia and AD pathology in the hippocampus or temporal cortex. In 
all three regions, men were less likely than women to have rod-shaped microglia, but this 
effect was only significant in the parietal cortex (Fig 4B, Table 2).
Bachstetter et al. Page 5
Neurobiol Aging. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Finally, comparing a self-reported history of TBI with a loss of consciousness to the 
presence of rod-shaped microglia yielded no significant association (Fig 5A). No association 
was found between the severity of TBI, as determined by an extended period of loss of 
consciousness and the presence of rod-shaped microglia (Fig 5B). As some of the cases with 
a history of TBI had the exposure more than 6 decades before their death, we sought to 
compare only those cases with a TBI more proximal to the time of death. However, no 
significant association was found between the presence of rod-shaped microglia, and the 
individuals who had a first TBI exposure after the age of 60 years old (Fig 5C).
4. Discussion
The present study investigated the clinical-pathological correlations associated with the 
occurrence of rod-shaped microglia in postmortem hippocampal and cortical tissue. Using 
two independent autopsy series, we found that age was one of the strongest determinants of 
the presence of rod-shaped microglia in the hippocampus and the cortex. We found no 
association with the presence of rod-shaped microglia and a self-reported history of a TBI. 
Alzheimer’s disease related pathology was found to influence the presence of rod-shaped 
microglia, but only in the parietal cortex and not in the hippocampus or temporal cortex. 
This suggests that increased activation of microglia (number or hypertrophic morphology) as 
seen in Alzheimer’s disease does not explain the increase number of rod-shaped microglia in 
the brain. This is in agreement with our previous study, where we found a very weak 
correlation between the total number of microglia in the CA1 region of the hippocampus and 
the number of rod-shaped microglia (R2 = 0.008; p=0.28 Spearman r) (Bachstetter et al., 
2015). Thus, our results highlight that rod-shaped microglia may be more common than 
once believed, particularly in individuals over age 70, and that the increased prevalence of 
rod-shaped microglia cannot be explained by simply larger numbers of microglia or more 
activated microglia.
4.1 Potential functions of rod-shaped microglia
Experimentally, the most faithful way to induce rod-shaped microglia is by an interruption in 
axonal transport either caused by a traumatic brain injury, optic nerve transection, or 
axotomy (Ackman et al., 2006, Bachstetter et al., 2015, de Hoz et al., 2013, Sanders et al., 
2014, Streit et al., 1999, Yuan et al., 2015, Ziebell et al., 2012). Deficits in axonal transport 
are thought to be an early molecular mechanism leading to neuronal loss in age-related 
neurodegenerative diseases (Morfini et al., 2009). In the current study it is not possible to 
determine if the rod-shaped microglia are associated specifically with neurons with deficits 
in axonal transport. The occurrence of rod-shaped microglia in more than one brain region in 
older individuals, as we found in this study, could indicate an age-related brain-wide change 
inhibiting axonal transport. The lack of a strong association of rod-shaped microglia with 
any one neurodegenerative disease, as we found in this study and in our previous work 
(Bachstetter et al., 2015), could be explained by the shared degenerative mechanism of 
axonal transport deficits seen in aging and age-related neurodegenerative diseases (Morfini 
et al., 2009).
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The function of rod-shaped microglia is largely unknown. There has been some speculation 
that rod-shaped microglia might provide a protective function to neurons, potentially by 
surrounding less damaged neurons to promote survival of the neurons (Streit et al., 1999, 
Trapp et al., 2007, Ziebell et al., 2012). Mechanistically, the neuroprotection could be 
imparted through the process of synaptic stripping, to alter the excitability of the weakened 
neuron (Trapp et al., 2007). Rod-shaped microglia may also provide trophic support through 
some yet to be identified mechanism that would appear to be contact dependent (Streit et al., 
1999). An intriguing possibility would be that rod-shaped microglia are involved in a 
process of mitochondria transfer, as was recently shown for astrocytes following stroke 
(Hayakawa et al., 2016), however more work is needed to test this possibility.
4.2 Potential chemotaxis signals for the formation of rod-shaped microglia
The presence of rod-shaped microglia associated with specific neurons, while adjacent 
neurons are not associated with rod-shaped microglia, would suggest an active neuron-
microglia signal regulating the specificity of rod-shaped microglia to individual neurons. 
Neurons are able to interact directly with microglia through a number of neuron-microglia 
specific signaling pathways. A well-documented example of such a signaling pathway is the 
neuron ligand, CX3CL1 and the microglia receptor, CX3CR1. The CX3CR1-CX3CL1 
pathway is vital for the suppression of inflammatory responses from microglia. Importantly, 
this pathway has been shown to be dysfunctional with age (Bachstetter et al., 2011, Corona 
et al., 2010, Lyons et al., 2009). The age-related loss of CX3CL1 may reduce the contact 
inhibition signals, thereby priming the aged brain for the formation of rod-shaped microglia. 
Yet, rod-shaped microglia are not a defining feature in CX3CR1 KO mice (Cardona et al., 
2006, Rogers et al., 2011), so it is unlikely that this pathway is a sole driver for the 
formation of rod-shaped microglia. Thus, there must also be a chemotaxis signal that is 
released from the neuron to cause the recruitment of the microglia to the neuron. As 
microglia, have been shown to constantly make brief contact with neurons (Tremblay et al., 
2010), the chemotaxis signal could be contact dependent and not a soluble factor released 
from the neurons.
The AI-ACT study includes an extensive array of histological and biochemical information, 
including RNAseq. A superficial exploration of this data did not reveal any proteins or genes 
at the tissue level that were associated with the presence or absence of rod-shaped microglia. 
As rod-shaped microglia account for only a small percentage of the total microglia 
population (Bachstetter et al., 2015), and the total microglia population only accounts for 5–
20% of the total glia population (van Rossum and Hanisch, 2004), it is likely at the tissue 
level a rod-shaped microglia molecular signature may not be evident. Future studies using 
laser capture microdissection would be needed to isolate individual neurons that are 
associated with rod-shaped microglia and adjacent neurons and microglia which are not in 
close association. Then a subtractive analysis could be done to determine the molecular 
signature unique to the neuron associated with the rod-shaped microglia and that of the rod-
shaped microglia, compared to the adjacent neurons and microglia.
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4.3 Limitations and future directions
A limitation of the study is that the AI-ACT series over-represents males and individuals 
with a history of TBI, compared to the community-based sample of the larger Adult 
Changes in Thought study. Methods for weighted analyses to extrapolate results to the larger 
cohort are provided by AI (© 2016 Allen Institute for Brain Science. Aging, Dementia and 
TBI. Available from: http://aging.brain-map.org/overview/explore), but were not used for 
this study. Therefore, findings reported should be seen as specific to the AI-ACT series and 
may not be representative of the larger cohort or the population in general. A second 
limitation of our study is that more than half of the cases with a history of TBI, had the first 
exposure to TBI many decades before death; thus, it is reasonable to assume that rod-shaped 
microglia may have resolved over time. A third limitation of our study was that it was not 
possible with the tissue available to provide a design-based stereological quantification of 
the total number of microglia; thus, we cannot account for the effect of age-related increase 
in microglia density that may influence the likelihood of detecting rod-shaped microglia in 
the older aged individuals.
A striking finding was the lack of rod-shaped microglia in the hippocampus of individuals 
aged 40–69 years old. Leading causes of death are known to change across age groups. 
Therefore, we hypothesized that differences in cause of death in the 40–69 years old group 
could be associated with the lack of rod-shaped microglia in this group. In the younger 
individuals (aged 20–69 years old), rod-shaped microglia were not found in the cases where 
the cause of death was either cardiac associated, drug abuse, or sepsis. Rod-shaped microglia 
were found in cases of pulmonary embolism, liver failure, or cancer. A limitation of this 
study was that cause of death was known for only a subset of the individuals 60 years old or 
older, so associations between cause of death and rod-shaped microglia could not be fully 
determined. Future studies specifically investigating the relationship of cause of death and 
rod-shaped microglia may be warranted.
4.4 Conclusion
In summation, our results highlight that aging, but not necessarily Alzheimer’s disease or a 
history of TBI, is a defining feature in the presence of rod-shaped microglia in the human 
brain. Future studies are warranted to determine the functional relevance of rod-shaped 
microglia in supporting the health of neurons in the aged brain, and the signaling processes 
that regulate the formation of rod-shaped microglia.
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• Rod-shaped microglia are associated with aging in human hippocampus and 
cortex.
• Alzheimer’s disease influences the presence of rod-shaped microglia.
• A history of traumatic brain injury was not associated with rod-shaped 
microglia.
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Figure 1. Examples of rod-shaped microglia from the UK series
(A) Numerous rod-shaped microglia are found throughout the CA1 region of the 
hippocampus of an 86-year-old female. The arrow indicates the area shown at a higher 
magnification in (B). (C) Long thin rod-shaped microglia, which appear to be surrounding a 
pyramidal neuron, in the subiculum of a 39-year-old male, who had hypoxia / ischemia 
pathology, and a pulmonary associated cause of death. (D) Example of rod-shaped microglia 
seen in the frontal cortex of a 28-year-old female, who died of atherosclerotic disease. (E) A 
number of long trains of rod-shaped microglia were found in the CA1 region of the 
hippocampus of a 25-year-old female, who had hypoxia / ischemia pathology, and a 
pulmonary associated cause of death. Scale bar = 50μm
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Figure 2. Association of aging on the presence of rod-shaped microglia
(A) In the hippocampus a significant trend was found for an increasing occurrence of rod-
shaped microglia with increasing age (p=0.017, Cochran Armitage Trend Test). (B) A 
significant increase in the occurrence of rod shaped microglia in the hippocampus was found 
in those individuals 70-years or older (70+) at the time of death, compared to those 
individuals 20–69-years old at the time of death (p=0.0033, Fisher Exact test) (C) A similar 
pattern was found for the frontal cortex when plotted as age by decade (p=0.222, Cochran-
Armitage Trend Test), or split into young adults (20–69-years old) and older adults (70+) 
(p=0.089, Fisher Exact test). The number of cases in each group are shown in the bars.
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Figure 3. Regional heterogeneity in the occurrence of rod-shaped microglia in younger adults 
versus aged adults
Cases were subdivided by which brain region(s) rod-shaped microglia were found, as 
follows: 1) in both the cortex and the hippocampus, 2) in the hippocampus only, 3) in the 
cortex only. In younger adults (20–69 years old) rod shaped microglia were found in the 
hippocampus, or in the frontal cortex, which is in contrast to the older adults (70+ years old) 
(p=0.047, χ2 test). The number of cases in each group are shown in the bars.
Bachstetter et al. Page 14
Neurobiol Aging. Author manuscript; available in PMC 2018 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. Association of age and sex on the presence of rod-shaped microglia
The presence of rod-shaped microglia was determined in cases from the AI-ACT series. (A) 
Age at the time of death was found to significantly contribute to an increase percentage of 
cases positive for the presence of rod-shaped microglia. (B) Sex was also found to effect the 
odds ratio that rod-shaped microglia would be found. See table 2 for summary or results. 
The number of cases in each group are shown in the bars.
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Figure 5. Association between a history of traumatic brain injury (TBI) and the presence of rod-
shaped microglia in AI-ACT series
(A) A self-reported history of at least one TBI with a loss of consciousness of at least a few 
seconds was not found associated with the presence of rod-shaped microglia. No association 
with the presence of rod-shaped microglia was found with either: (B) a self-reported history 
of at least one TBI with a loss of consciousness of more than 10 min; or a first TBI exposure 
after the age of 60 years old. The number of cases in each group are shown in the bars.
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Table 1
Case series characteristics
UK series AI-ACT series
Number of cases 61 107
Age
20–29 6 (9.8%) 0 (0%)
30–39 12 (19.7%) 0 (0%)
40–49 7 (11.5%) 0 (0%)
50–59 6 (9.8%) 0 (0%)
60–69 4 (6.6%) 0 (0%)
70–79 5 (8.2%) 12 (11.2%)
80–89 16 (26.2%) 45 (42.1%)
90–99 5 (8.2%) 43 (40.2%)
100+ 0 (0%) 7 (7.5%)
Sex
Male 27 (43.3%) 63 (58.9%)
Female 31 (50.8%) 44 (41.1%)
Dementia status
No dementia 61 (100%) 57 (53.3%)
Dementia 0 (0%) 50 (46.7%)
Braak NFT stage
0/I/II 61 (100%) 28 (26.2%)
III/IV 0 (0%) 44 (41.1%)
V/VI 0 (0%) 32 (29.9%)
CERAD rating
None 61 (100%) 24 (22.4%)
Sparse 0 (0%) 33 (30.8%)
Moderate 0 (0%) 25 (23.4%)
Frequent 0 (0%) 25 (23.4%)
Number of cases and percent of total cases for the series are shown in the table. Abbreviations: University of Kentucky bio tissue repository series 
of cases (UK series). The Aging, Dementia and Traumatic Brain Injury Study series (© 2016 Allen Institute for Brain Science. Aging, Dementia 
and TBI. Available from: http://aging.brain-map.org/overview/explore) (AI-ACT series). Braak neurofibrillary tangle (NFT) Stage. Consortium to 
Establish a Registry for Alzheimer’s Disease (CERAD)
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